Catalent, which also fills vaccine vials for Moderna, suffered a setback in the US when tuning up its automated visual verification line, which makes checks on vials, according to people familiar with the matter. The company has said it will deliver 4 million doses immediately, fewer than the 10 million the US government originally expected. Mike Riley, president of Catalent Biologics, North America, said it was on track to meet its vaccine production commitments to all customers, including Moderna and J&J. “Short-term variations are normal when initiating new production processes to rapidly increase the supply of safe, high-quality vaccines,” he said. It said it was confident it would meet its targets for the US, of 100 million by June 2021, and the EU, which has ordered 200 million doses in 2021.

Source: The Irish Times March 01, 2021 13:11 UTC